Saenger S, Holtmann B, Nilges MR, Schroeder S, Hoeflich A, Kletzl H, Spooren W, Ostrowitzki S, Hanania T, Sendtner M et al (2012) Functional improvement in mouse models of familial amyotrophic lateral sclerosis by pegylated insulin-like growth factor i treatment depends on disease severity
May help with recovery and reducing perceived exertion
Not recommended for persons under 18 years of age, pregnant or breastfeeding women, and people with increased nervous excitability, insomnia or arterial hypertension
Metabolic Syndrome Research Tirz has also been studied in the context of metabolic syndrome, a cluster of conditions including elevated blood pressure, abnormal lipid profiles, insulin resistance, and excess body fat
FDA registration of the facility does not constitute FDA approval or endorsement of any compounded medication.